Quince Therapeutics, Inc.
QNCX
$1.63
$0.021.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.71M | 31.60M | 40.78M | 47.85M | 59.45M |
| Total Receivables | 992.00K | 916.00K | 882.00K | 995.00K | 964.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 527.00K | 758.00K | 986.00K | 1.41M | 725.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.12M | 556.00K | 1.38M | 1.47M | 2.30M |
| Total Current Assets | 37.35M | 33.83M | 44.04M | 51.72M | 63.44M |
|
|
|||||
| Total Current Assets | 37.35M | 33.83M | 44.04M | 51.72M | 63.44M |
| Net Property, Plant & Equipment | 1.08M | 941.00K | 813.00K | 767.00K | 800.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 67.57M | 62.37M | 60.05M | 464.00K | 450.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.14M | 9.88M | 9.51M | 73.49M | 70.06M |
| Total Assets | 117.21M | 107.09M | 114.48M | 126.52M | 134.83M |
|
|
|||||
| Total Accounts Payable | 1.76M | 3.01M | 2.90M | 1.62M | 2.41M |
| Total Accrued Expenses | 5.42M | 5.01M | 3.97M | 3.50M | 2.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 112.00K | 102.00K | 96.00K | 101.00K | 94.00K |
| Total Finance Division Other Current Liabilities | 180.00K | 233.00K | 308.00K | 198.00K | 5.28M |
| Total Other Current Liabilities | 180.00K | 233.00K | 308.00K | 198.00K | 5.28M |
| Total Current Liabilities | 7.47M | 8.36M | 7.28M | 5.43M | 10.32M |
|
|
|||||
| Total Current Liabilities | 7.47M | 8.36M | 7.28M | 5.43M | 10.32M |
| Long-Term Debt | 16.99M | 15.27M | 14.32M | 14.90M | 13.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 387.00K | 383.00K | 394.00K | 450.00K | 453.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 80.63M | 64.50M | 62.34M | 60.81M | 63.25M |
| Total Liabilities | 105.47M | 88.51M | 84.33M | 81.59M | 87.86M |
|
|
|||||
| Common Stock & APIC | 413.13M | 408.13M | 406.65M | 405.53M | 404.40M |
| Retained Earnings | -407.55M | -391.50M | -376.47M | -364.01M | -358.52M |
| Treasury Stock & Other | 6.16M | 1.96M | -35.00K | 3.42M | 1.09M |
| Total Common Equity | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M |
|
|
|||||